Full Text View
Tabular View
No Study Results Posted
Related Studies
Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
This study is ongoing, but not recruiting participants.
First Received: September 14, 2005   Last Updated: October 4, 2006   History of Changes
Sponsors and Collaborators: Stanford University
California Breast Cancer Research Program
Genentech
Amgen
Johnson & Johnson
Google
Information provided by: Stanford University
ClinicalTrials.gov Identifier: NCT00186602
  Purpose

Women indicate the greatest needs for counseling at the time of initial diagnosis for primary breast cancer. The time of initial diagnosis is also often the time of greatest need for information for women and their families. However, this is the time when a woman, overwhelmed by shock and trauma, is least likely to absorb information provided or seek new sources of information. An informed peer navigator with carefully trained communication skills can judge the level of information to disclose and pace that information in a way that can be easily absorbed and understood. She will also provide support.

WomenCARE, a well-established Santa Cruz agency providing free support services for women with cancer, and the Psychosocial Treatment Lab at Stanford therefore ask whether women newly diagnosed with breast cancer will improve their quality of life by participating in a peer navigator program.

WomenCARE's peer navigators provide emotional support, good listening skills, and information on resources for women just diagnosed with breast cancer.

Having a peer counselor while a woman goes through treatment may reduce the magnitude of distress or shorten its time course. It may also reduce distress in family members, and improve relationships with medical personnel. This study is designed to evaluate the effectiveness of a peer navigator program where a woman newly diagnosed with breast cancer is carefully matched for 3 to 6 months after diagnosis with a trained volunteer who is herself a breast cancer survivor. Navigators and Sojourners (newly diagnosed women) are matched on things that are important to them. Women often want to be matched on the type of surgery or treatment they have received. We assign half of the women (by a process similar to a coin toss) to our peer navigator program and half to a group that receives standard medical care but no peer navigator. In this way we can compare the groups to see whether those matched with a peer navigator have better quality of life over the 3 to 6 month period. All women who join our study, regardless of the group to which they are assigned, get an extra consultation with a nurse specialist at a local hospital. In this consultation, the nurse reviews the cancer resources available to the woman in Santa Cruz County. This meeting is tailored to the woman’s individual diagnosis and situation.


Condition Intervention Phase
Breast Cancer
Behavioral: Peer counseling
Phase II

Genetics Home Reference related topics: breast cancer
MedlinePlus related topics: Breast Cancer Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment
Official Title: Does a Peer Navigator Improve Quality of Life at Diagnosis?
  Eligibility

Ages Eligible for Study:   20 Years to 85 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

women within 2 months of diagnosis of breast cancer can read English within the catchment area of Watsonville and Santa Cruz California -

Exclusion Criteria:

women who have previously had a peer navigator intervention women who have a chronic history of hospitalization for psychiatric reason

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186602

Locations
United States, California
WomenCARE
Santa Cruz, California, United States, 95061
Sponsors and Collaborators
Stanford University
California Breast Cancer Research Program
Genentech
Amgen
Johnson & Johnson
Google
Investigators
Principal Investigator: David Spiegel, M.D. Stanford University
Principal Investigator: Caroline Bliss-Isberg, Ph.D. Cabrillo College
Study Director: Janine Giese-Davis, Ph.D. Stanford University
  More Information

No publications provided

Study ID Numbers: 7BB-2400
Study First Received: September 14, 2005
Last Updated: October 4, 2006
ClinicalTrials.gov Identifier: NCT00186602     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Skin Diseases
Quality of Life
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Skin Diseases
Breast Neoplasms
Breast Diseases

ClinicalTrials.gov processed this record on May 07, 2009